Trial intelligence / Profile preview

Buccal midazolam premedication for pediatric dental general anesthesia

jRCTs031230610Active, not recruiting

Start
Mar 2024
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of midazolam. Primary endpoint: Mask acceptance at 20 minutes. Started Mar 2024; status: active, not recruiting.

02

Drugs

midazolam

Beyond the preview

Go deeper on jRCTs031230610.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs031230610.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call